(-)-Mandelic acid
規格
611-71-2CAS番号
210-276-6EC番号
(2R)-2-hydroxy-2-phenylacetic acidIUPAC名
C8H8O3化学式
152.15 g/mol分子量
611-71-2; (r)-mandelic acid; (R)-2-Hydroxy-2-phenylacetic acid; D-Mandelic acid; (-)-Mandelic acid; D(-)-Mandelic acid; Mandelic acid, (R)-; D-2-Phenylglycolic acid; (-)-(R)-Mandelic acid; (R)-alpha-Hydroxyphenylacetic acid; (R)-alpha-Hydroxybenzeneacetic acid; Mandelic acid, D-; (-)-alpha-Hydroxyphenylacetic acid; PPL7YW1M9W; CHEBI:17656; RefChem:905564; 210-276-6; (R)-(-)-Mandelic acid; D-(-)-MANDELIC ACID; (2R)-2-hydroxy-2-phenylacetic acid; (R)-Hydroxy(phenyl)acetic acid; R-(-)-Mandelic acid; MFCD00064251; Sertraline EP Impurity E; (R)-Mandelsaeure; (R)-A-Hydroxyphenylacetic acid; DTXSID4046523; (2R)-hydroxy(phenyl)acetic acid; (2R)-2-hydroxy-2-phenyl-acetic acid; CHEMBL292411; (2R)-hydroxy(phenyl)ethanoic acid; mandelic_acid; R(-)-Mandelic Acid; mandelic-acid; RMN; DTXCID2026523; (R)-(-)-Amygdalic Acid; CAS-611-71-2; (-)-D-MANDELIC ACID; (2R)-Hydroxyphenylacetic Acid ((R)-Mandelic Acid); Benzeneacetic acid, .alpha.-hydroxy-, (.alpha.R)-; UNII-PPL7YW1M9W; (L)-(+)-Mandelic acid; (R)-2-Phenylglycolic acid; 1mcz; 1mdl; L-2-Hydroxy-2-phenylacetic acid; (-)-mandelate; NCGC00166022-01; d - mandelic acid; EINECS 210-276-6; D-2-Phenylglycolate; (R)-ALPHA-HYDROPHENYLACETIC ACID; (-)-(R)-Mandelate; (r)(-)-mandelic acid; Benzeneacetic acid, alpha-hydroxy-, (-)-; Maybridge1_004148; (r)-(-) mandelic acid; Sertraline impurity E CRS; (R)-(+)-mandelic acid; (R)-a-Hydroxyphenylacetate; (R)-Hydroxyphenylaceticacid; Benzeneacetic acid, alpha-hydroxy-, (alphaR)-; (-)-a-Hydroxyphenylacetate; (R)-a-Hydroxybenzeneacetate; Hydroxy-phenyl-acetate anion; (R)-(-)- mandelic acid; (r)-(-)-d-mandelic acid; Oprea1_502663; cid_11914; SCHEMBL165161; (-)-alpha-Hydroxyphenylacetate; (R)-alpha-Hydroxyphenylacetate; orb1304715; (-)-a-Hydroxyphenylacetic acid; (R)-alpha-Hydroxybenzeneacetate; (R)-a-Hydroxybenzeneacetic acid; SCHEMBL29777368; BDBM16421; HMS553E14; HY-Y0585R; D,L-mandelic acid redetermination; Hydroxy-Phenyl-Acetic Acid Anion; (R)-a-Hydroxy-benzeneacetic acid; D-(-)-Mandelic acid (Standard); HMS3650C13; R-(−)-Mandelic Acid; (R)-(-)-Mandelic acid, 98%; HY-Y0585; STR08136; Tox21_112292; EBC-44251; (2R)-HYDROXYPHENYLACETIC ACID; AKOS005256699; Tox21_112292_1; AC-2490; CCG-266220; CS-W020074; DB02280; FM25007; T2S0122; (-)-(R)alpha-hydroxybenzeneacetic acid; (-)-(R) alpha-hydroxybenzeneacetic acid; MSK163406-1000M; NCGC00166022-02; SY001645; Benzeneacetic acid, alpha-hydroxy-, (R)-; M0662; NS00098847; (R)-.ALPHA.-HYDROXYBENZENEACETIC ACID; C01983; D70151; EN300-100159; MLS-0090888.0001; D-(-)-Mandelic acid, purum, >=98.0% (T); D-(-)-Mandelic acid, puriss., >=99.0% (T); F093732; SR-01000946767; (R)-(-)-Mandelic acid, ReagentPlus(R), >=99%; (R)-Mandelic acid Solution in Methanol, 1000ug/mL; SR-01000946767-1; Q63390533; (R)-(-)-Mandelic acid, Vetec(TM) reagent grade, 98%; F1905-7046; SERTRALINE HYDROCHLORIDE IMPURITY E [EP IMPURITY]; Z1255390767; 08C65DF7-6DDF-44B3-9490-02A43D9D33C1; (R)-(-)-Mandelic acid, ChiPros(R), produced by BASF, 99%; Sertraline impurity E, European Pharmacopoeia (EP) Reference Standard別名
